Envista Holdings Corporation (BMV:NVST)
Mexico · Delayed Price · Currency is MXN | Market Cap | 66.74B +19.3% |
| Revenue (ttm) | 50.16B +12.1% |
| Net Income | 1.21B |
| EPS | 7.29 |
| Shares Out | n/a |
| PE Ratio | 55.18 |
| Forward PE | 16.17 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,007 |
| Average Volume | 773 |
| Open | 370.00 |
| Previous Close | 354.27 |
| Day's Range | 370.00 - 370.00 |
| 52-Week Range | 352.53 - 370.00 |
| Beta | n/a |
| RSI | n/a |
| Earnings Date | May 6, 2026 |
About Envista Holdings
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, ... [Read more]
News
Envista Holdings Transcript: AGM 2026
The meeting covered board elections, auditor ratification, and executive compensation, with all proposals passing by majority vote. A quorum was present, and no stockholder questions were submitted during the Q&A session.
Envista Q1 Earnings Call Highlights
Envista NYSE: NVST reported a strong start to 2026, with management citing broad-based growth across its major dental businesses, margin expansion and continued investment in new products and commerci...
Envista price target raised to $31 from $30 at Baird
Baird analyst Jeff Johnson raised the firm’s price target on Envista (NVST) to $31 from $30 and keeps an Outperform rating on the shares. The firm updated its model following…
Envista price target raised to $29 from $26 at JPMorgan
JPMorgan raised the firm’s price target on Envista (NVST) to $29 from $26 and keeps a Neutral rating on the shares.
Envista price target raised to $33 from $30 at Evercore ISI
Evercore ISI analyst Elizabeth Anderson raised the firm’s price target on Envista (NVST) to $33 from $30 and keeps an Outperform rating on the shares.
Envista Holdings Earnings Call Transcript: Q1 2026
Q1 2026 saw robust 9.5% core sales growth, double-digit gains in key segments, and 25% adjusted EBITDA growth. Guidance for 2026 is reaffirmed, with a $300 million share repurchase authorized and continued investment in innovation and M&A.
Envista Holdings Earnings release: Q1 2026
Envista Holdings released its Q1 2026 earnings on May 6, 2026, summarizing the period's financial results.
Envista Holdings Quarterly report: Q1 2026
Envista Holdings has published its Q1 2026 quarterly earnings report on May 6, 2026.
Envista Holdings Slides: Q1 2026
Envista Holdings has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 6, 2026.
Envista Reports First Quarter 2026 Results
BREA, Calif., May 6, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended April 3, 2026.
Envista price target raised to $21 from $19 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Envista (NVST) to $21 from $19 and keeps an Equal Weight rating on the shares. The firm’s U.S. dental survey suggests softer…
Envista initiated with a Neutral at Citi
Citi analyst Daniel Grosslight initiated coverage of Envista (NVST) with a Neutral rating and $29 price target The firm launched the animal health and dental sectors with a “cautiously optimistic”…
Envista Schedules First Quarter 2026 Earnings Call
BREA, Calif., April 8, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its first quarter 2026 on Wednesday, May 6, 2026.
Envista price target lowered to $30 from $32 at Evercore ISI
Evercore ISI lowered the firm’s price target on Envista (NVST) to $30 from $32 and keeps an Outperform rating on the shares. The firm made several price target adjustments and…
Envista Holdings Proxy statement: Proxy filing
Envista Holdings filed a proxy statement on April 7, 2026, providing details for shareholder voting and corporate governance matters.
Envista Holdings Proxy statement: Proxy filing
Envista Holdings filed a proxy statement on April 7, 2026, providing details for shareholder voting and corporate governance matters.
Envista price target raised to $32 from $28 at BofA
BofA analyst Allen Lutz raised the firm’s price target on Envista (NVST) to $32 from $28 and keeps a Buy rating on the shares. Following earnings, the firm is raising…
Envista price target raised to $30 from $27 at Baird
Baird raised the firm’s price target on Envista (NVST) to $30 from $27 and keeps an Outperform rating on the shares. The firm updated its model following solid results driven…
Envista price target raised to $19 from $18 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Envista (NVST) to $19 from $18 and keeps an Equal Weight rating on the shares. Q4 upside and 2026 guidance were “encouraging,”…
Envista price target raised to $32 from $26 at Evercore ISI
Evercore ISI analyst Elizabeth Anderson raised the firm’s price target on Envista (NVST) to $32 from $26 and keeps an Outperform rating on the shares following EBITDA and EPS beats…
Envista price target raised to $31 from $27 at Stifel
Stifel raised the firm’s price target on Envista (NVST) to $31 from $27 and keeps a Buy rating on the shares. The company seems to be growing market plus across…
Envista price target raised to $26 from $22 at JPMorgan
JPMorgan raised the firm’s price target on Envista (NVST) to $26 from $22 and keeps a Neutral rating on the shares. The company reported strong Q4 results with “reasonable” 2026…
Envista price target raised to $25 from $21 at Piper Sandler
Piper Sandler analyst Jason Bednar raised the firm’s price target on Envista (NVST) to $25 from $21 and keeps a Neutral rating on the shares. The firm notes Q4 was…
Leerink upgrades Envista to Outperform on improved growth, execution
As previously reported, Leerink upgraded Envista (NVST) to Outperform from Market Perform with a price target of $35, up from $25. The firm cites improved growth and execution from Envista…
Envista upgraded to Outperform from Market Perform at William Blair
William Blair analyst Brandon Vazquez upgraded Envista (NVST) to Outperform from Market Perform without a price target The company’s Q4 beat and 2026 outlook shows execution on its turnaround, the…